NCT04575870

Brief Summary

Patients undergo laryngotracheal anesthesia (LTA) for a variety of in-office laryngology procedures. Prior to resolution of laryngeal sensory anesthesia, oral intake may predispose patients to aspiration. The purpose of this study is to objectively characterize a time period for return of aspiration-free swallow after LTA.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 5, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

November 18, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

2.2 years

First QC Date

August 7, 2020

Last Update Submit

April 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Modified functional endoscopic exam of swallowing (FEES)

    A modified functional endoscopic exam of swallowing (FEES) is an examination where a small amount of water will be ingested. Each subject will perform about three water swallows. Water will be dyed with green food coloring to facilitate visualization, as is standard with the FEES procedure. If the water passes normally to the esophagus, this will be considered a pass; if the water is aspirated, this will be considered a fail.

    Up to 90 minutes

Study Arms (3)

Treatment Group 1: 90 min waiting period

Participants undergo their planned tracheobronchoscopy + 90 minute waiting period prior to modified functional endoscopic swallowing exam

Other: waiting period

Treatment Group 2: 66 min waiting period

Participants undergo their planned tracheobronchoscopy + 66 minute waiting period prior to modified functional endoscopic swallowing exam

Other: waiting period

Treatment Group 3: 46 min waiting period

Participants undergo their planned tracheobronchoscopy + 46 minute waiting period prior to modified functional endoscopic swallowing exam

Other: waiting period

Interventions

amount of time between clinical procedure and modified functional endoscopic exam of swallowing

Treatment Group 1: 90 min waiting periodTreatment Group 2: 66 min waiting periodTreatment Group 3: 46 min waiting period

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing treatment for airway stenosis who present to the University of Alabama at Birmingham Voice Center.

You may qualify if:

  • Age 18 years or older
  • Ability of patients to speak and understand English
  • Ability for patients to consent for themselves
  • Undergoing tracheobronchoscopy procedure for the treatment of airway stenosis
  • Eating Assessment Tool (EAT-10) score ≤ 3

You may not qualify if:

  • Age less than 18 years
  • Patients unable or unwilling to provide informed consent
  • Women who are pregnant
  • History of abnormal swallowing evaluation, either videofluroscopic study of swallow or functional endoscopic evaluation of swallowing (FEES)
  • History of medical condition affecting swallowing, such as
  • Neurodegenerative disorders: stroke, traumatic brain injury, dementia, motor neuron disease, myasthenia gravis, cerebral palsy, Gullain-Barre syndrome, poliomyelitis, myopathy, Parksonism, Huntingon's disease, progressive supranuclear palsy, Wilson's disease, vocal fold paralysis
  • Connective tissue disorders: polymyositis, dermatomyositis, progressive systemic sclerosis, Sjogren's disease, scleroderma
  • History of gastroesophageal tumor
  • History of gastroesophageal surgery
  • History of recent open central neck surgery (i.e., thyroidectomy, anterior cervical discectomy or fusion)
  • History of head and neck cancer
  • History of head and neck radiation therapy or chemotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Aerophagy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Blake Simpson, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 7, 2020

First Posted

October 5, 2020

Study Start

November 18, 2020

Primary Completion

January 31, 2023

Study Completion

January 31, 2023

Last Updated

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations